Quantification of O-(2-[18F]fluoroethyl)-L-tyrosine kinetics in glioma

被引:13
|
作者
Koopman, Thomas [1 ]
Verburg, Niels [2 ,3 ]
Schuit, Robert C. [1 ]
Pouwels, Petra J. W. [1 ]
Wesseling, Pieter [4 ,5 ,6 ]
Windhorst, Albert D. [1 ]
Hoekstra, Otto S. [1 ]
Hamer, Philip C. de Witt [2 ,3 ]
Lammertsma, Adriaan A. [1 ]
Boellaard, Ronald [1 ,7 ]
Yaqub, Maqsood [1 ]
机构
[1] Vrije Univ Amsterdam Med Ctr, Dept Radiol & Nucl Med, POB 7057, NL-1007 MB Amsterdam, Netherlands
[2] Vrije Univ Amsterdam Med Ctr, Neurosurg Ctr Amsterdam, Amsterdam, Netherlands
[3] Brain Tumor Ctr Amsterdam, Amsterdam, Netherlands
[4] Vrije Univ Amsterdam Med Ctr, Dept Pathol, Amsterdam, Netherlands
[5] Princess Maxima Ctr Pediat Oncol, Dept Pathol, Utrecht, Netherlands
[6] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands
[7] Univ Med Ctr Groningen, Dept Nucl Med & Mol Imaging, Groningen, Netherlands
来源
EJNMMI RESEARCH | 2018年 / 8卷
关键词
FET; Quantification; Kinetic modelling; SUV; SUVR; POSITRON-EMISSION-TOMOGRAPHY; REFERENCE TISSUE MODEL; PET; BRAIN; BINDING; TRANSPORT; F-18-FET; TUMORS;
D O I
10.1186/s13550-018-0418-0
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Background: This study identified the optimal tracer kinetic model for quantification of dynamic O-(2-[F-18] fluoroethyl)-L-tyrosine ([F-18]FET) positron emission tomography (PET) studies in seven patients with diffuse glioma (four glioblastoma, three lower grade glioma). The performance of more simplified approaches was evaluated by comparison with the optimal compartment model. Additionally, the relationship with cerebral blood flow-determined by [O-15]H2O PET-was investigated. Results: The optimal tracer kinetic model was the reversible two-tissue compartment model. Agreement analysis of binding potential estimates derived from reference tissue input models with the distribution volume ratio (DVR)-1 derived from the plasma input model showed no significant average difference and limits of agreement of -0.39 and 0.37. Given the range of DVR-1 (-0.25 to 1.5), these limits are wide. For the simplified methods, the 60-90 min tumour-to-blood ratio to parent plasma concentration yielded the highest correlation with volume of distribution V-T as calculated by the plasma input model (r = 0.97). The 60-90 min standardized uptake value (SUV) showed better correlation with V-T (r = 0.77) than SUV based on earlier intervals. The 60-90 min SUV ratio to contralateral healthy brain tissue showed moderate agreement with DVR with no significant average difference and limits of agreement of -0.24 and 0.30. A significant but low correlation was found between V-T and CBF in the tumour regions (r = 0.61, p = 0.007). Conclusion: Uptake of [F-18] FET was best modelled by a reversible two-tissue compartment model. Reference tissue input models yielded estimates of binding potential which did not correspond well with plasma input-derived DVR-1. In comparison, SUV ratio to contralateral healthy brain tissue showed slightly better performance, if measured at the 60-90 min interval. SUV showed only moderate correlation with V-T. V-T shows correlation with CBF in tumour.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Quantification of O-(2-[18F]fluoroethyl)-L-tyrosine kinetics in glioma
    Thomas Koopman
    Niels Verburg
    Robert C. Schuit
    Petra J. W. Pouwels
    Pieter Wesseling
    Albert D. Windhorst
    Otto S. Hoekstra
    Philip C. de Witt Hamer
    Adriaan A. Lammertsma
    Ronald Boellaard
    Maqsood Yaqub
    [J]. EJNMMI Research, 8
  • [2] Quantitative parametric maps of O-(2-[18F]fluoroethyl)-L-tyrosine kinetics in diffuse glioma
    Koopman, Thomas
    Verburg, Niels
    Pouwels, Petra J. W.
    Wesseling, Pieter
    Hoekstra, Otto S.
    Hamer, Philip C. De Witt
    Lammertsma, Adriaan A.
    Yaqub, Maqsood
    Boellaard, Ronald
    [J]. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2020, 40 (04): : 895 - 903
  • [3] Strategy based on kinetics of O-(2-[18F] fluoroethyl)-L-tyrosine ([18F] FET)
    Masashi Kameyama
    Yumi Umeda-Kameyama
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2016, 43 : 2267 - 2268
  • [4] Strategy based on kinetics of O-(2-[18F] fluoroethyl)-L-tyrosine ([18F] FET)
    Kameyama, Masashi
    Umeda-Kameyama, Yumi
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 (12) : 2267 - 2268
  • [5] Value of O-(2-[18F]fluoroethyl)-L-tyrosine PET for the diagnosis of recurrent glioma
    Pöpperl, G
    Götz, C
    Rachinger, W
    Gildehaus, FJ
    Tonn, JC
    Tatsch, K
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 (11) : 1464 - 1470
  • [6] Value of O-(2-[18F]fluoroethyl)-l-tyrosine PET for the diagnosis of recurrent glioma
    Gabriele Pöpperl
    Claudia Götz
    Walter Rachinger
    Franz-Josef Gildehaus
    Jörg-Christian Tonn
    Klaus Tatsch
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2004, 31 : 1464 - 1470
  • [7] The synthesis of O-( 2-[18F] fluoroethyl)-L-tyrosine (FET) in NPI
    Svecova, H.
    Prochazka, L.
    Fedorova, O. S.
    Kropacek, M.
    Melichar, F.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 : S331 - S331
  • [8] Evaluation of O-(2-[18F]-Fluoroethyl)-L-Tyrosine in the Diagnosis of Glioblastoma
    Benouaich-Amiel, Alexandra
    Lubrano, Vincent
    Tafani, Mathieu
    Uro-coste, Emmanuelle
    Gantet, Pierre
    Sol, Jean Christophe
    Roux, Franck
    Bousquet, Philippe
    Julian, Anne
    Sabatier, Jean
    Tremoulet, Michel
    Cances-Lauwers, Valerie
    Delisle, Marie Bernadette
    Clanet, Michel
    Esquerre, Jean Philippe
    Payoux, Pierre
    [J]. ARCHIVES OF NEUROLOGY, 2010, 67 (03) : 370 - 372
  • [10] O-(2-[18F]fluoroethyl)-L-tyrosine:: uptake mechanisms and clinical applications
    Langen, KJ
    Hamacher, K
    Weckesser, M
    Floeth, F
    Stoffels, G
    Bauer, D
    Coenen, HH
    Pauleit, D
    [J]. NUCLEAR MEDICINE AND BIOLOGY, 2006, 33 (03) : 287 - 294